Castle Biosciences (CSTL) Goodwill (2022 - 2026)

Castle Biosciences has reported Goodwill for 5 years, with the latest figure at $10.7 million in Q2 2026.

• Quarterly Goodwill changed 0.0% year-over-year to $10.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $10.7 million (changed 0.0% YoY) and the FY2025 annual result came in at $10.7 million, changed 0.0% from the prior year.
• Goodwill steadied at $10.7 million in Q2 2026 per CSTL's latest filing, from $10.7 million in the prior quarter.
• Over five years, Goodwill peaked at $10.7 million in Q4 2022 and troughed at $10.5 million in Q3 2022.
• A 5-year average of $10.7 million and a median of $10.7 million in 2022 frame the typical range for Goodwill.
• The widest YoY moves for Goodwill: up 2.04% in 2023, down 0.0% in 2023.
• Over 5 years, Goodwill stood at $10.7 million in 2022, then changed by 0.0% to $10.7 million in 2023, then changed by 0.0% to $10.7 million in 2024, then changed by 0.0% to $10.7 million in 2025, then changed by 0.0% to $10.7 million in 2026.
• According to Business Quant data, Goodwill over the past three periods registered $10.7 million, $10.7 million, and $10.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.